PDF] Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase | Semantic Scholar
Frontiers | Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer
Network pharmacology analysis reveals potential targets and mechanisms of proton pump inhibitors in breast cancer with diabetes | Scientific Reports
IJMS | Free Full-Text | Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver
pantoprazole | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Trend of inappropriate orders for target drugs (%) before and after the... | Download Scientific Diagram
PDF] Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase | Semantic Scholar
Degradation of Pantoprazole in aqueous solution using magnetic nanoscaled Fe3O4/CeO2 composite: Effect of system parameters and degradation pathway - ScienceDirect
Cancers | Free Full-Text | Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells